Literature DB >> 1561696

Are hemostatic factors responsible for the paradoxical risk factors for coronary heart disease and stroke?

M Gliksman1, A Wilson.   

Abstract

BACKGROUND: The paradoxical occurrence of a high risk of stroke in some populations at low risk for coronary heart disease has long been known. Recently, evidence has appeared linking the paradoxical risk to population-based differences in diet, serum cholesterol, and alcohol intake. However, the pathophysiological mechanism of action that would explain this paradox is unlikely to be atherosclerosis alone. SUMMARY OF COMMENT: Several recent cross-sectional and prospective population studies have shown that hemostatic factors vary between populations in a manner consistent with the paradox. Studies have also shown that certain hemostatic factors are independent predictors of risk of coronary heart disease, ischemic stroke, and, probably, hemorrhagic stroke.
CONCLUSIONS: Risk factors that enhance thrombosis and reduce fibrinolysis are capable of explaining the paradoxical occurrence of the incidence of coronary heart disease and stroke in certain populations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1561696     DOI: 10.1161/01.str.23.4.607

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  2 in total

1.  D-dimer and the Risk of Stroke and Coronary Heart Disease. The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Neil A Zakai; Leslie A McClure; Suzanne E Judd; Brett Kissela; George Howard; Monika Safford; Mary Cushman
Journal:  Thromb Haemost       Date:  2016-12-22       Impact factor: 5.249

2.  In-hospital prognosis of first-ever noncardiogenic ischemic stroke in patients with and without indication for prestroke antiplatelet therapy: Chinese Stroke Center Alliance.

Authors:  Yu-Yuan Xu; Hong-Qiu Gu; Zi-Xiao Li; Yun-Yun Xiong; Qi Zhou; Li-Ping Liu; Xing-Quan Zhao; Yi-Long Wang; Xia Meng; Yong-Jun Wang
Journal:  Ann Transl Med       Date:  2021-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.